Humanigen $72 million stock PIPE offering
Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Humanigen Inc. of $72 million of common stock.
Humanigen Inc. is a clinical…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Investments in GOJEK by Facebook, PayPal, Google and Tencent
Davis Polk is advising PT Aplikasi Karya Anak Bangsa (“GOJEK”) in connection with the investments by Facebook, PayPal, Google, Tencent and other investors, focused on supporting GOJEK’s…
Ralph Lauren $1.25 billion notes offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered offering by Ralph Lauren Corporation of $500 million aggregate…
Xi’an Aerospace High-Tech Industry Development $200 million bond offering
Davis Polk advised the joint lead managers on a Regulation S offering by Xi’an Aerospace High-Tech Industry Development Co., Ltd, a company incorporated in the People’s Republic of China…
Appian $141.2 million stock offering
Davis Polk advised the sole bookrunner in connection with the SEC-registered offering of 2,500,000 shares of Class A common stock of Appian Corporation by Appian and certain existing…
Atara Biotherapeutics $175 million stock and pre-funded warrants offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…
NuVasive $400 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $400 million aggregate principal amount of its 1.000%…
Penumbra $143.75 million follow-on offering
Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 865,963 shares of common stock for an aggregate price to the public of approximately $143.75 million,…
Silicon Laboratories $535 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Silicon Laboratories Inc. of $535 million aggregate principal amount of its…
1Life Healthcare $275 million convertible senior notes offering
Davis Polk advised the joint book-running managers and representatives of the initial purchasers in connection with a Rule 144A offering by 1Life Healthcare, Inc. of $275 million…